Friday, July 24 Company Presentations 5–Diagnostics, Device, NPO
Name /ACT Genomics
Address /3F., No.345, Xinhu 2nd Rd., Neihu Dist., Taipei City 114, Taiwan (R.O.C.)
To get the whole picture of molecular profile in cancer, ACT Genomics’ technology overcomes genomic sequencing barrier for a broad application. Served as the genomic lens, ACT Genomics leads innovative integration among clinical treatment, cancer research and drug development, ensuring personal medical journey with better quality of life. ACT Genomics’ services covers cancer patients’ treatment and their families’ prevention; difficult situations in late-stage cancer can be managed with ACT Genomics’ superior panel design.
Based in Asia, ACT Genomics’ premium-quality database featuring high success rate in sequencing and top-notch bioinformatics analysis offers new direction for Precision Medicine.
ACT Genomics provides NGS-based multiple genomic profiling options for tumor cell according to clinical needs. Report turnaround time ranges from 12-14 calendar days.
ACT Genomics provides NGS-based genomic profiling option for hereditary risk evaluation according to clinical needs. Report turnaround time is 30 calendar days.
ACT Genomics provides chip-based multiplex PCR genomic profiling option for tumor microenvironment according to research needs. Report turnaround time in 2 hours.
Name /Luke Chen